niacinamide has been researched along with Nerve Sheath Neoplasms in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Nerve Sheath Neoplasms: Neoplasms which arise from nerve sheaths formed by SCHWANN CELLS in the PERIPHERAL NERVOUS SYSTEM or by OLIGODENDROCYTES in the CENTRAL NERVOUS SYSTEM. Malignant peripheral nerve sheath tumors, NEUROFIBROMA, and NEURILEMMOMA are relatively common tumors in this category.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Malignant peripheral nerve sheath tumors (MPNSTs) have high malignant potential and poor prognosis because of aggressive progression and metastasis." | 1.43 | Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells. ( Goto, K; Iino, M; Kikuchi, N; Tanaka, T, 2016) |
| "Malignant schwannomas or malignant peripheral nerve sheath tumors (MPNST) represent approximately 10% of all soft tissue sarcomas." | 1.35 | Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review. ( Fenning, R; Gudena, V; Kizziah, M; Montero, AJ; Post, G; Verma, N, 2008) |
| "Malignant peripheral nerve sheath tumors (MPNST) are soft-tissue tumors with a very poor prognosis and largely resistant to chemotherapy." | 1.35 | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells. ( Ambrosini, G; Cheema, HS; Sambol, EB; Schwartz, GK; Seelman, S; Singer, S; Teed, A, 2008) |
| "Malignant peripheral nerve sheath tumors are rare spindle-cell sarcomas derived from Schwann cells or pluripotent cells of the neural crest." | 1.33 | Spinal cord metastasis of a non-neurofibromatosis type-1 malignant peripheral nerve sheath tumor: an unusual manifestation of a rare tumor. ( Baek, WS; Pytel, P; Rubeiz, H; Undevia, SD, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, T | 1 |
| Kikuchi, N | 1 |
| Goto, K | 1 |
| Iino, M | 1 |
| Baek, WS | 1 |
| Pytel, P | 1 |
| Undevia, SD | 1 |
| Rubeiz, H | 1 |
| Gudena, V | 1 |
| Verma, N | 1 |
| Post, G | 1 |
| Kizziah, M | 1 |
| Fenning, R | 1 |
| Montero, AJ | 1 |
| Ambrosini, G | 1 |
| Cheema, HS | 1 |
| Seelman, S | 1 |
| Teed, A | 1 |
| Sambol, EB | 1 |
| Singer, S | 1 |
| Schwartz, GK | 1 |
4 other studies available for niacinamide and Nerve Sheath Neoplasms
| Article | Year |
|---|---|
Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-X Protein; Cell Line, Tumor; Doxorubi | 2016 |
Spinal cord metastasis of a non-neurofibromatosis type-1 malignant peripheral nerve sheath tumor: an unusual manifestation of a rare tumor.
Topics: Adult; Benzenesulfonates; Chemotherapy, Adjuvant; Fatal Outcome; Female; Humans; Lung Neoplasms; Mag | 2005 |
Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review.
Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Brain Neoplasms; Female; Humans; Lung Neoplasms; Ma | 2008 |
Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.
Topics: Antineoplastic Agents; Apoptosis; Benzenesulfonates; Blotting, Western; Cell Differentiation; Cell P | 2008 |